Plasma pharmacokinetics after combined therapy of gemcitabine and oral S-1 for unresectable pancreatic cancer

BACKGROUND: The combination of gemcitabine (GEM) and S-1, an oral 5-fluorouracil (5-FU) derivative, has been shown to be a promising regimen for patients with unresectable pancreatic cancer. METHODS: Six patients with advanced pancreatic cancer were enrolled in this pharmacokinetics (PK) study. Thes...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Nakata, Bunzo, Amano, Ryosuke, Nakao, Shigetomi, Tamura, Tatsuro, Shinto, Osamu, Hirakawa, Toshiki, Okita, Yoshihiro, Yamada, Nobuya, Hirakawa, Kosei
Formato: Artigo
Idioma:Inglês
Publicado em: BioMed Central 2010
Assuntos:
Research
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC2838818/
https://ncbi.nlm.nih.gov/pubmed/20181235
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1756-9966-29-15
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados